$15 Billion Acquisition

In a move that drastically reshapes the medical device landscape, Boston Scientific Corporation (NYSE: BSX) officially announced a definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) on January 15, 2026. The deal, valued at approximately $14.5 to $15 billion, represents one of the largest med-tech acquisitions in recent years and cements Boston Scientific’s dominance in…